IL115275A - Method for the preparation of 3-hydroxy-5-¬2-(dimethylamino)-ethy¾-2,3-dihydro-4(methoxy-phenyl)-1,5-benzothiazepin-4(5H)-one - Google Patents

Method for the preparation of 3-hydroxy-5-¬2-(dimethylamino)-ethy¾-2,3-dihydro-4(methoxy-phenyl)-1,5-benzothiazepin-4(5H)-one

Info

Publication number
IL115275A
IL115275A IL11527595A IL11527595A IL115275A IL 115275 A IL115275 A IL 115275A IL 11527595 A IL11527595 A IL 11527595A IL 11527595 A IL11527595 A IL 11527595A IL 115275 A IL115275 A IL 115275A
Authority
IL
Israel
Prior art keywords
benzothiazepin
dihydro
dimethylamino
hydroxy
preparation
Prior art date
Application number
IL11527595A
Other languages
English (en)
Other versions
IL115275A0 (en
Original Assignee
Orion Corp Fermion
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Corp Fermion filed Critical Orion Corp Fermion
Publication of IL115275A0 publication Critical patent/IL115275A0/xx
Publication of IL115275A publication Critical patent/IL115275A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D281/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D281/02—Seven-membered rings
    • C07D281/04—Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D281/08—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D281/10—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL11527595A 1994-09-16 1995-09-12 Method for the preparation of 3-hydroxy-5-¬2-(dimethylamino)-ethy¾-2,3-dihydro-4(methoxy-phenyl)-1,5-benzothiazepin-4(5H)-one IL115275A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP94114643A EP0702009B1 (en) 1994-09-16 1994-09-16 Method for the preparation of pharmaceutically active benzothiazepine derivatives

Publications (2)

Publication Number Publication Date
IL115275A0 IL115275A0 (en) 1995-12-31
IL115275A true IL115275A (en) 2000-06-01

Family

ID=8216292

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11527595A IL115275A (en) 1994-09-16 1995-09-12 Method for the preparation of 3-hydroxy-5-¬2-(dimethylamino)-ethy¾-2,3-dihydro-4(methoxy-phenyl)-1,5-benzothiazepin-4(5H)-one

Country Status (20)

Country Link
US (1) US5663332A (xx)
EP (1) EP0702009B1 (xx)
JP (1) JPH08269026A (xx)
AT (1) ATE167858T1 (xx)
BA (1) BA95040A (xx)
CA (1) CA2158223A1 (xx)
CZ (1) CZ290970B6 (xx)
DE (1) DE69411387T2 (xx)
DK (1) DK0702009T3 (xx)
EE (1) EE03565B1 (xx)
ES (1) ES2118292T3 (xx)
HR (1) HRP950478B1 (xx)
HU (1) HU220610B1 (xx)
IL (1) IL115275A (xx)
LV (1) LV11324B (xx)
PL (1) PL310495A1 (xx)
RU (1) RU2141957C1 (xx)
SK (1) SK281219B6 (xx)
YU (1) YU60395A (xx)
ZA (1) ZA957703B (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996038429A1 (en) * 1995-06-01 1996-12-05 Acic (Canada) Inc. Method for the manufacture of benzothiazepine derivatives
IL123352A0 (en) 1997-02-27 1998-09-24 Tanabe Seiyaku Co Process for preparing an optically active trans-3-substituted glycidic acid ester
DE102004010830A1 (de) * 2004-02-27 2005-09-15 Bioagency Ag Neue 1,4-Benzooxazepane oder 1,4-Benzothiazepane und Derivate
CN103304514B (zh) * 2013-06-28 2014-09-17 天津梅花医药有限公司 一种稳定性好的盐酸地尔硫卓化合物及药物组合物

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3562257A (en) * 1967-10-28 1971-02-09 Tanabe Seiyaku Co Benzothiazepine derivatives
JPS5899471A (ja) * 1981-12-07 1983-06-13 Tanabe Seiyaku Co Ltd ベンゾチアゼピン誘導体の新規製造法
IT1175814B (it) * 1984-03-09 1987-07-15 Luso Farmaco Inst Resine solfoniche ad attivita' terapeutica,loro preparazione e composizioni farmaceutiche che le contengono
JPS63275572A (ja) * 1987-05-01 1988-11-14 Tanabe Seiyaku Co Ltd １，５−ベンゾチアゼピン誘導体
FR2624117B1 (fr) * 1987-12-08 1991-02-22 Synthelabo Derives de hydroxy-3 (methoxy-4 phenyl)-2 (methylamino-2 ethyl)-5 dihydro-2,3 5h-benzothiazepine-1,5 one-4, leur preparation et leur application en therapeutique
FR2630109B1 (fr) * 1988-04-19 1991-11-29 Synthelabo Derives de ((n-(amino-2 oxo-2 ethyl)methylamino)-2 ethyl)-5 hydroxy-3 (methoxy-4 phenyl)-2 dihydro-2,3 5h-benzothiazepine-1,5 one-4, leur preparation et leur application en therapeutique
US5002942A (en) * 1988-07-25 1991-03-26 Sankyo Company, Limited 1,5-benzothiazepine derivatives, their preparation and their use in the treatment of cardiovascular disorders
FR2653122B1 (fr) * 1989-10-17 1994-04-15 Synthelabo Derives de 5-[2-[[2-amino-2-oxoethyl]methylamino]ethyl]-2,3-dihydro-3-hydroxy-2-(4-methoxyphenyl)-1,5(5h)-benzothiazepine-4-one, leur preparation et leur application en therapeutique.
IT1240686B (it) * 1990-04-27 1993-12-17 Luso Farmaco Inst Derivati 1,5-benzotiazepinonici, loro preparazione e uso farmaceutico
IT1244878B (it) * 1990-12-11 1994-09-12 Lusochimica Spa Processo per la preparazione del (+)-cis-3-(acetossi)-5-!2-( dimetilammino)etil!-2,3-diidro-2-(4-metossifenil)-1,5-benzotiazepin- 4-(5h)-one cloridrato

Also Published As

Publication number Publication date
SK114195A3 (en) 1996-06-05
DE69411387T2 (de) 1999-02-25
BA95040A (bs) 1998-12-28
DK0702009T3 (da) 1999-02-01
SK281219B6 (sk) 2001-01-18
RU2141957C1 (ru) 1999-11-27
CZ290970B6 (cs) 2002-11-13
ES2118292T3 (es) 1998-09-16
EP0702009A1 (en) 1996-03-20
PL310495A1 (en) 1996-03-18
IL115275A0 (en) 1995-12-31
LV11324A (lv) 1996-06-20
HRP950478A2 (en) 1997-06-30
EE03565B1 (et) 2001-12-17
DE69411387D1 (de) 1998-08-06
ZA957703B (en) 1996-04-24
HU220610B1 (hu) 2002-03-28
CZ237295A3 (en) 1996-04-17
ATE167858T1 (de) 1998-07-15
LV11324B (en) 1996-10-20
EE9500050A (et) 1996-04-15
HRP950478B1 (en) 1999-10-31
US5663332A (en) 1997-09-02
CA2158223A1 (en) 1996-03-17
HUT76924A (hu) 1998-01-28
HU9502710D0 (en) 1995-11-28
YU60395A (sh) 1998-09-18
JPH08269026A (ja) 1996-10-15
EP0702009B1 (en) 1998-07-01

Similar Documents

Publication Publication Date Title
CA2295792A1 (en) A crystalline dibenzothiazepine derivative and its use as an antipsychotic agent
IL81234A (en) Peptidylaminodiols,process for their preparation and pharmaceutical compositions comprising them
EG18584A (en) Process for preparing of 1-phenyl-3 naphthalenyloxypropanamines
EA200100301A3 (ru) НОВЫЙ СПОСОБ ПОЛУЧЕНИЯ 11-АМИНО-3-ХЛОР-6,11-ДИГИДРО-5,5-ДИОКСО-6-МЕТИЛДИБЕНЗО[c,f][1,2]ТИАЗЕПИНА И ЕГО ПРИМЕНЕНИЕ ДЛЯ СИНТЕЗА ТИАНЕПТИНА
CA2354606A1 (en) Azabicycloalkane derivatives and therapeutic uses thereof
HUT36127A (en) Process for preparing new pyrrolo-benzoxazepines
IL115275A (en) Method for the preparation of 3-hydroxy-5-¬2-(dimethylamino)-ethy¾-2,3-dihydro-4(methoxy-phenyl)-1,5-benzothiazepin-4(5H)-one
AU4889496A (en) Pyrrolocarbazole derivatives
EP0156734A3 (fr) Triazolo[4,3-b]pyridazines, procédé pour leur préparation et compositions pharmaceutiques les contenant
ES2039166A1 (es) Proceso para la preparacion de benzodiacepinas por ciclizacion con acidos fosfonicos.
AU657423B2 (en) Novel piperidine derivatives and process for preparation thereof
MD1574C2 (ro) Săruri de alchilamoniu ale acidului N,N1-malonil-bis-p-aminobenzoic, procedeu de obţinere şi utilizarea lor în calitate de remediu hipotensiv şi antiaritmic

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed